Low estrogen receptor (ER) positive breast cancer and neoadjuvant systemic therapy (NAT): Is response similar to ER plus or to ER- disease?

被引：1

作者：

Landmann, Alessandra

Farrugia, Daniel J.

Diego, Emilia

Soran, Atilla

Johnson, Ronald

Bonaventura, Marguerite

Dabbs, David J.

Clark, Beth

Brufsky, Adam

Davidson, Nancy E.

Lembersky, Barry C.

Jankowitz, Rachel Catherine

Puhalla, Shannon

Ahrendt, Gretchen M.

McAuliffe, Priscilla F.

Bhargava, Rohit

机构：

[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[2] Univ Pittsburgh, Pittsburgh, PA USA

[3] UPMC, Magee Womens Hosp, Pittsburgh, PA USA

[4] Magee Womens Hosp, Pittsburgh, PA USA

[5] Magee Womens Hosp, Dept Path, Pittsburgh, PA USA

[6] NRG Oncol NSABP, Pittsburgh, PA USA

[7] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA

来源：

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.580

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

580

引用

页数：2